Cadrenal Therapeutics Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$1.08

+0.01 (+0.93%)

As of Sep 21, 5:46 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +1,469.4% upside

Low Target $12.65

Average Target $16.95

High Target $22.59

Current Price $1.08

Current
$1.08

Target
$16.95

$12.65 $16.95 avg $22.59

Scenario Analysis

Bear Case

$12.65

1,071.3%

Low target

Base Case

$16.95

+1,469.4%

Avg target

Bull Case

$22.59

+1,991.7%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$14.64

-92.6% from high

52-Week Low

$1.00

+8.0% from low

Target vs 52W High

$16.95

+15.8% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+13.7%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+11.3%
MRK Merck & Co. Inc.	Buy	36	72%	$159.27	+5.5%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+21.4%
BMY Bristol-Myers Squibb Co	Hold	35	43%	$174.50	+180.3%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-38.0%
ZTS Zoetis Inc	Hold	24	50%	$209.87	+188.0%